DROSPIRENONE-BASED CONTRACEPTIVE FOR A FEMALE PATIENT AFFECTED WITH EXCESS WEIGHT

Drospirenone as the sole contraceptive ingredient comprised in a daily active dosage unit in an amount of at least 3 mg for use as a contraceptive for a female patient affected with obesity.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BOYER-JOUBERT, Cecile, DROUIN, Dominique, PERRIN, Philippe
Format: Patent
Sprache:eng ; hun
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Drospirenone as the sole contraceptive ingredient comprised in a daily active dosage unit in an amount of at least 3 mg for use as a contraceptive for a female patient affected with obesity.